ABUS - Arbutus Biopharma GAAP EPS of -$0.12 beats by $0.01 revenue of $5.95M misses by $3.23M
- Arbutus Biopharma press release ( NASDAQ: ABUS ): Q3 GAAP EPS of -$0.12 beats by $0.01 .
- Revenue of $5.95M (+78.1% Y/Y) misses by $3.23M .
- As of September 30, 2022, the Company had cash, cash equivalents and investments in marketable securities of $190.2 million, as compared to $191.0 million as of December 31, 2021.
For further details see:
Arbutus Biopharma GAAP EPS of -$0.12 beats by $0.01, revenue of $5.95M misses by $3.23M